Clinical Trial Update: Pharmacogenetics-Based Study on Individualized Use of Sodium Valproate [Phase 4]

View source ↗

Summary

Phase 4 pharmacogenetics-based study investigating individualized use of sodium valproate in epilepsy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Sodium valproate (valproate)

Snippet

Sponsor: The First Affiliated Hospital of University of South China | Conditions: Epilepsy | Phase 4 | Status: RECRUITING